207940.KSKOSPI
Samsung Biologics Co.,Ltd.
1,609,000.00+1.51%1d
Data as of Aug 25, 2026 · end-of-day snapshot
Volume signal tierC
Alert levelinsufficient_liquidity
Tier and alert level are a summary. Unlock 207940.KS to see the full accumulation read: relative-volume ratios, z-scores, money-flow and float turnover behind this signal.
+2.22%, upReturn · 1w
+3.87%, upReturn · 1m
+18.05%, upReturn · 3m
+2.60%, upReturn · 1y
−19.02%vs 52-week high
Technicals
Technical readings
The latest end-of-day reading across momentum, trend and volatility signals, included free on every stock page.
Automated read
The moving-average structure shows no decisive trend in either direction: the mid-term picture reads as rangebound. RSI is currently 62.
RSI (14)61.65, favorable readingUpper-neutral
MACD / signal38,442.73 / 37,505.75, favorable readingAbove signal line
SMA 501,451,360.00, favorable readingPrice above
SMA 2001,593,689.85, favorable readingPrice above
EMA 201,537,592.68, favorable readingPrice above
ADX (14)17.63Rangebound
+DI / −DI29.64 / 16.35+DI leading
ATR (14)50,714.293.2% of price — typical daily swing
Stochastic %K78.57Mid-range
Bollinger bands (20)1,442,139.31 – 1,633,560.69Inside bands
ROC (10)0.00Flat
Trend / momentum impulseBoth rising, favorable impulse readingTrend and momentum agree
Readings as of Aug 25, 2026 · end-of-day snapshot
Full analysis
What unlocking 207940.KS reveals
Sample preview: figures are illustrative.
Company & theme write-up
Signal history
AI narrative
Catalysts & risks
Accumulation read
Unlock
207940.KS: full analysis
AI narrative · signals & history · social sentiment · full fundamentals
$9.90 USD
one-time · 30-day access
- Unlocked in about 60 seconds
- 30-day access
- No account needed
Analyzing a few names? Get 5 for $25.00 or 15 for $49.00: one-time, 30 days for the whole pack, swaps included.
Free weekly sample report
Get a full sample stock analysis in your inbox every week, no card, just the same read you see here on one hand-picked ticker.
Earnings
When does Samsung Biologics Co.,Ltd. report earnings?
Samsung Biologics Co.,Ltd. (207940.KS) is scheduled to report earnings on Oct 27, 2026.
The date is confirmed rather than estimated, though companies do occasionally reschedule.
Data as of Aug 26, 2026
See who else reports soonNeed the raw data?Get 207940.KS + ~22,000 stocks as a clean CSV: every column, ready to load into a spreadsheet or notebook.
Build a dataset $9.90one-time Unlock 207940.KS